Long-term debt · 2016–2025

Sinovac Biotech long-term debt

$495M+31.7% · FY2025

Sinovac Biotech (SVA) reported $495M in long-term debt for fiscal 2025, +31.7% year on year.

$40.7M2016$33.0M2017$7.2M2018$5.9M2019$35.1M2020$15.8M2021$11.8M2022$254M2023$376M2024$495M2025
Sinovac Biotech — Long-term debt, 2016–2025
Fiscal yearLong-term debtChangeFiling
FY20252025-12-31$495M+31.7%Open →
FY20242024-12-31$376M+48.0%Open →
FY20232023-12-31$254M+2,050.7%Open →
FY20222022-12-31$11.8M−25.1%Open →
FY20212021-12-31$15.8M−55.1%Open →
FY20202020-12-31$35.1M+491.4%Open →
FY20192019-12-31$5.9M−17.7%Open →
FY20182018-12-31$7.2M−78.1%Open →
FY20172017-12-31$33.0M−19.0%Open →
FY20162016-12-31$40.7M—Open →

Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +32.0%

Long-term debt at companies of similar size

Full ranking by long-term debt →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Sinovac Biotech long-term debt |url=https://companiesranked.com/en/company/sinovac-biotech/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Sinovac Biotech long-term debt. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/long-term-debt

BibTeX

@misc{companiesranked-en-company-sinovac-biotech-long-term-debt-2026,
  author       = {{CompaniesRanked}},
  title        = {{Sinovac Biotech long-term debt}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/long-term-debt}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026

{{cite web |title=Sinovac Biotech long-term debt — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Sinovac Biotech overview